Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Efstathiou

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Clinical Lymphoma|January 11, 2003
Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemiaMeletios A Dimopoulos, Constantinos Zervas, Athanasios Zomas, et al.
The Prostate|July 4, 2012
Integrated Hedgehog signaling is induced following castration in human and murine prostate cancersEleni Efstathiou, Maria Karlou, Sijin Wen, et al.
European Urology|July 9, 2015
Metastatic Prostate Cancer and the Bone: Significance and Therapeutic OptionsBenjamin A Gartrell, Robert Coleman, Eleni Efstathiou, et al.
Leukemia & Lymphoma|July 12, 2003
Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamideMeletios A Dimopoulos, George Hamilos, Eleni Efstathiou, et al.
Plos One|February 25, 2012
Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancerKanishka Sircar, Heng Huang, Limei Hu, et al.
Anticancer Research|March 14, 2007
Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcomeEleni Efstathiou, Meletios A Dimopoulos, George Bozas, et al.
Cancer Biology & Therapy|November 20, 2008
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesisChun Chui Tsao, Bin T Teh, Eric Jonasch, et al.
Pathology|December 23, 2019
Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progressionVasiliki Tzelepi, Souzana Logotheti, Eleni Efstathiou, et al.
Gynecologic Oncology|June 8, 2002
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology GroupMeletios A Dimopoulos, Christos A Papadimitriou, Kyrillos Sarris, et al.
Anticancer Research|April 22, 2011
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survivalEvangelos Bournakis, Eleni Efstathiou, Andreas Varkaris, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Clinical Lymphoma|January 11, 2003
Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemiaMeletios A Dimopoulos, Constantinos Zervas, Athanasios Zomas, et al.
The Prostate|July 4, 2012
Integrated Hedgehog signaling is induced following castration in human and murine prostate cancersEleni Efstathiou, Maria Karlou, Sijin Wen, et al.
European Urology|July 9, 2015
Metastatic Prostate Cancer and the Bone: Significance and Therapeutic OptionsBenjamin A Gartrell, Robert Coleman, Eleni Efstathiou, et al.
Leukemia & Lymphoma|July 12, 2003
Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamideMeletios A Dimopoulos, George Hamilos, Eleni Efstathiou, et al.
Plos One|February 25, 2012
Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancerKanishka Sircar, Heng Huang, Limei Hu, et al.
Anticancer Research|March 14, 2007
Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcomeEleni Efstathiou, Meletios A Dimopoulos, George Bozas, et al.
Cancer Biology & Therapy|November 20, 2008
Inhibition of Mxi1 suppresses HIF-2alpha-dependent renal cancer tumorigenesisChun Chui Tsao, Bin T Teh, Eric Jonasch, et al.
Pathology|December 23, 2019
Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progressionVasiliki Tzelepi, Souzana Logotheti, Eleni Efstathiou, et al.
Gynecologic Oncology|June 8, 2002
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology GroupMeletios A Dimopoulos, Christos A Papadimitriou, Kyrillos Sarris, et al.
Anticancer Research|April 22, 2011
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survivalEvangelos Bournakis, Eleni Efstathiou, Andreas Varkaris, et al.
Pageof 15